Alnylam Pharmaceuticals, Inc.
NASDAQ:ALNY · NASDAQ Global Select
-$6.27 today
Vol 1.77M · Avg 1.11M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-11.19%
Period High
$491.22
Period Low
$278.09
Latest
$278.09
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Cigna Corporation
NYSE:CI
$74.25B
Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN
$62.16B
argenx SE
NASDAQ:ARGX
$54.47B
Cencora, Inc.
NYSE:COR
$52.84B
Cardinal Health, Inc.
NYSE:CAH
$52.30B
Becton, Dickinson and Company
NYSE:BDX
$52.24B
Edwards Lifesciences Corporation
NYSE:EW
$50.28B
IDEXX Laboratories, Inc.
NASDAQ:IDXX
$44.08B
Zoetis Inc.
NYSE:ZTS
$32.85B
Veeva Systems Inc.
NYSE:VEEV
$24.76B
What is the latest ALNY filing?
The latest filing shown is 3 dated Jun 3, 2026.
How many recent filings does ALNY have?
Intrinsic Alpha currently shows 20 recent filings for ALNY.
Explore More
Continue the stock analysis
Jump to another research area for this company.